GlassScriptPhysician profile
Jennifer E Trottman
NPI 1457393696
$3,660.00
in general payments reported to CMS, 2019-2025
40 companies · $1,447 in 2025
The $1,447 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $727 · 2020: $227 · 2021: $283 · 2022: $183 · 2023: $356 · 2024: $436 · 2025: $1,447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,047 · Education: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,046.72 |
| Education | $192.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $526.80 | 2019-2025 | |
| Daiichi Sankyo INC. | $512.88 | 2020-2025 | Enhertu, Datroway |
| Lilly USA, LLC | $272.78 | 2019-2025 | Jaypirca, Verzenio |
| Pfizer INC. | $265.36 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $225.08 | 2020-2025 | Lynparza, Enhertu, Imfinzi |
| Janssen Biotech, INC. | $141.94 | 2019-2025 | Erleada, Darzalex, Talvey |
| E.R. Squibb & Sons, L.L.C. | $141.33 | 2019-2023 | Opdivo |
| Seagen INC. | $128.85 | 2019-2023 | Padcev |
| Abbvie INC. | $127.07 | 2019-2025 | |
| Astellas Pharma US INC | $120.12 | 2020-2021 | |
| Genzyme Corporation | $117.81 | 2019-2025 | |
| Taiho Oncology, INC. | $102.63 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $92.93 | 2022-2025 | Iclusig, Ninlaro, Advate |
| Dendreon Pharmaceuticals LLC | $87.66 | 2025 | Provenge |
| Aveo Pharmaceuticals, INC. | $81.61 | 2024-2025 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Trottman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.